Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · IEX Real-Time Price · USD
2.180
-0.360 (-14.17%)
At close: Jul 2, 2024, 3:59 PM
2.260
+0.080 (3.67%)
After-hours: Jul 2, 2024, 7:28 PM EDT
Alpha Tau Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Alpha Tau Medical stock have an average target of 11.75, with a low estimate of 7.00 and a high estimate of 23. The average target predicts an increase of 438.99% from the current stock price of 2.18.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DRTS stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +312.84% | Jun 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +312.84% | May 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +312.84% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +312.84% | Mar 12, 2024 |
Piper Sandler | Piper Sandler | Buy Reiterates $8 → $7 | Buy | Reiterates | $8 → $7 | +221.10% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.51
from -0.42
EPS Next Year
-0.54
from -0.51
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 4.3M | 54.5M | 138.0M |
Avg | n/a | n/a | 4.2M | 40.7M | 134.0M |
Low | n/a | n/a | 4.0M | 27.3M | 128.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 1,213.1% | 239.0% |
Avg | - | - | - | 879.8% | 229.3% |
Low | - | - | - | 557.1% | 216.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.48 | -0.53 | -0.11 | -0.46 | 0.02 |
Avg | -0.51 | -0.54 | -0.37 | -0.52 | 0.02 |
Low | -0.54 | -0.56 | -0.62 | -0.57 | 0.02 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.